Jacqueline Kloos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jacqueline Kloos has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Rachel Weinerman
Division of Reproductive Endocrinology and Infertility, University Hospitals Cleveland Medical Center Cleveland Ohio USA
2 shared publicationsAlexandra Purdue-Smithe
Division of Women’s Health, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
1 shared publicationAnne Sammarco
Obstetrics and Gynecology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
1 shared publicationAria Bassiri
Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio
1 shared publicationBrenda Finucane
Geisinger Health System, Lewisburg
1 shared publicationCarol Walton
University of Colorado Anschutz Medical Campus
1 shared publication
Latest Publications
- 11 January 2024
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 41 (3) , 643-648
Similar pregnancy outcomes from fresh and frozen donor oocytes transferred to gestational carriers: a SART database analysis isolating the effects of oocyte vitrification
Purpose This work aimed to study clinical and neonatal outcomes of embryos derived from frozen compared to fresh donor oocytes in gestational carrier cycles. Methods This is a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database between 2014 and 2015, comprising of 1284 fresh transfer cycles to gestational carrier recipients of embryos resulting from fresh (n = 1119) and vitrified/thawed (n = 165) donor oocytes. Models were adjusted for gestational carrier age, preimplantation genetic testing (PGT-A), number of embryos transferred, multiple gestation, and fetal heart reduction. As our models were part of a larger analysis, intended parent BMI, smoking status, and parity were also adjusted for, but did not influence outcomes in this analysis. Results There was no significant difference in probability of live birth rates when comparing embryos derived from fresh and frozen donor oocytes in gestational carrier cycles. There were also no significant differences in biochemical pregnancy losses or clinical miscarriage. There were no significant differences noted in low birthweight or high birthweight infants derived from fresh versus frozen donor oocyte after transfer into a gestational carrier. Conclusions The analysis of fresh and frozen donor oocytes in gestational carrier cycles provides the opportunity to assess for a possible effect of vitrification on the oocyte by controlling for differences in the uterine environment. We observed no significant differences in live birth, pregnancy loss, low birthweight or high birthweight infants when comparing fresh and frozen donor oocytes in gestational carrier cycles.
- 11 January 2024
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 41 (3) , 643-648
Similar pregnancy outcomes from fresh and frozen donor oocytes transferred to gestational carriers: a SART database analysis isolating the effects of oocyte vitrification
Purpose This work aimed to study clinical and neonatal outcomes of embryos derived from frozen compared to fresh donor oocytes in gestational carrier cycles. Methods This is a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database between 2014 and 2015, comprising of 1284 fresh transfer cycles to gestational carrier recipients of embryos resulting from fresh (n = 1119) and vitrified/thawed (n = 165) donor oocytes. Models were adjusted for gestational carrier age, preimplantation genetic testing (PGT-A), number of embryos transferred, multiple gestation, and fetal heart reduction. As our models were part of a larger analysis, intended parent BMI, smoking status, and parity were also adjusted for, but did not influence outcomes in this analysis. Results There was no significant difference in probability of live birth rates when comparing embryos derived from fresh and frozen donor oocytes in gestational carrier cycles. There were also no significant differences in biochemical pregnancy losses or clinical miscarriage. There were no significant differences noted in low birthweight or high birthweight infants derived from fresh versus frozen donor oocyte after transfer into a gestational carrier. Conclusions The analysis of fresh and frozen donor oocytes in gestational carrier cycles provides the opportunity to assess for a possible effect of vitrification on the oocyte by controlling for differences in the uterine environment. We observed no significant differences in live birth, pregnancy loss, low birthweight or high birthweight infants when comparing fresh and frozen donor oocytes in gestational carrier cycles.
- Open Access
- 1 January 2024
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2024 (1) , 5421129
Intrapartum and 30‐Day Postpartum Complications in Patients With Antenatal COVID‐19 Infection: A Retrospective Cohort Study
Objective: The study was aimed at comparing intrapartum and postpartum outcomes between pregnant patients with and without antenatal COVID‐19 infection using aggregated, deidentified electronic health record (EHR) data.Design and Setting: This retrospective cohort study included data from over 80 health care organizations within the TriNetX Analytics Research Network.Population: Individuals admitted for delivery from Jan 2020 to May 2023 were studied.Methods: We studied individuals with ICD‐10 codes for delivery, COVID‐19 diagnosis, and primary outcomes. We compared the incidence of adverse intrapartum and 30‐day postpartum outcomes in those with and without antenatal COVID‐19.Main Outcome Measures: The main outcomes compared were obstetric, cardiovascular, neurovascular, and respiratory outcomes within 30 days postpartum.Results: Twenty‐six thousand nine hundred seventy‐four of 369,923 (7%) birthing parents with a delivery encounter had an antenatal COVID‐19 diagnosis. Compared to matched controls, having COVID‐19 was associated with an increased risk of postpartum hemorrhage (RR—1.24 (CI—1.16–1.33)), gestational hypertension (RR—1.27 (CI—1.27–1.34)), preeclampsia (RR—1.25 (CI—1.18–1.32)), eclampsia (RR—1.66 (CI—1.29–2.32)), preterm labor (RR—1.21 (CI—1.21–1.34)), cerebral infarction (RR—1.74 (CI—1.04–2.90)), cardiomyopathy (RR—2.08 (CI—1.30–3.32)), heart failure (RR—1.55 (CI—1.04–2.31)), sepsis (RR—2.21 (CI—1.54–3.19)), DVT (RR—2.32 (CI—1.45–3.71)), and pulmonary embolism (RR—2.68 (CI—1.74–2.90)).Conclusion: Individuals with antenatal COVID‐19 were more likely to have intrapartum and postpartum obstetric, cardiovascular, neurovascular, and respiratory complications. This data will inform risk stratification and screening for prenatal care providers.
- 1 January 2024
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2024 (1) , 5421129
Open AccessIntrapartum and 30‐Day Postpartum Complications in Patients With Antenatal COVID‐19 Infection: A Retrospective Cohort Study
Objective: The study was aimed at comparing intrapartum and postpartum outcomes between pregnant patients with and without antenatal COVID‐19 infection using aggregated, deidentified electronic health record (EHR) data.Design and Setting: This retrospective cohort study included data from over 80 health care organizations within the TriNetX Analytics Research Network.Population: Individuals admitted for delivery from Jan 2020 to May 2023 were studied.Methods: We studied individuals with ICD‐10 codes for delivery, COVID‐19 diagnosis, and primary outcomes. We compared the incidence of adverse intrapartum and 30‐day postpartum outcomes in those with and without antenatal COVID‐19.Main Outcome Measures: The main outcomes compared were obstetric, cardiovascular, neurovascular, and respiratory outcomes within 30 days postpartum.Results: Twenty‐six thousand nine hundred seventy‐four of 369,923 (7%) birthing parents with a delivery encounter had an antenatal COVID‐19 diagnosis. Compared to matched controls, having COVID‐19 was associated with an increased risk of postpartum hemorrhage (RR—1.24 (CI—1.16–1.33)), gestational hypertension (RR—1.27 (CI—1.27–1.34)), preeclampsia (RR—1.25 (CI—1.18–1.32)), eclampsia (RR—1.66 (CI—1.29–2.32)), preterm labor (RR—1.21 (CI—1.21–1.34)), cerebral infarction (RR—1.74 (CI—1.04–2.90)), cardiomyopathy (RR—2.08 (CI—1.30–3.32)), heart failure (RR—1.55 (CI—1.04–2.31)), sepsis (RR—2.21 (CI—1.54–3.19)), DVT (RR—2.32 (CI—1.45–3.71)), and pulmonary embolism (RR—2.68 (CI—1.74–2.90)).Conclusion: Individuals with antenatal COVID‐19 were more likely to have intrapartum and postpartum obstetric, cardiovascular, neurovascular, and respiratory complications. This data will inform risk stratification and screening for prenatal care providers.
- Open Access
- 29 December 2023
- Published by Wiley in Clinical Obesity
- Vol. 14 (3) , e12638
Increased body mass index is negatively associated with ovarian reserve as measured by anti‐Müllerian hormone in patients with polycystic ovarian syndrome
Summary: Anti‐Müllerian hormone (AMH) is commonly used as a marker of ovarian reserve. Although obesity is associated with decreased fertility, the relationship between body mass index (BMI) and AMH remains uncertain, hindering the accurate interpretation of AMH. We sought to assess the relationship between serum AMH and BMI in patients with and without polycystic ovarian syndrome (PCOS). This study analysed 500 patients at a single centre between 2020 and 2021. Patients were divided into cohorts: those with BMI 40 kg/m2. Patients with and without PCOS were included. Chi‐square tests, Fisher's exact tests, multiple linear regression analysis and independent t‐tests were performed as appropriate. In the general study population, serum AMH was not significantly different in the BMI >40 kg/m2 group compared to the BMI 2 group (4.3 ± 5.6 vs. 4.3 ± 5.6, p = .35). Patient ages between these two groups differed, with an average age of 35.4 ± 5.4 years in the BMI 2 group and 33.7 ± 5.4 years in the BMI 2 group (p = .031). Our multivariate regression analysis, which adjusted for age, demonstrated a significant interaction effect between BMI and PCOS diagnosis, indicating that the relationship between BMI and AMH is dependent on PCOS status (β = −.03, 95% confidence interval [CI]: −0.05, 0.00, p = .044). In patients without PCOS, we found a non‐significant relationship between AMH and BMI (β = .00, 95% CI −0.01, 0.01, p = .7); however, in patients with PCOS, AMH significantly decreased as BMI increased (β = −.03, 95% CI −0.06, 0.00, p = .034). BMI has an inverse association with AMH levels in patients with PCOS, indicating a need for future research to determine if that interaction represents a clinically significant negative effect on reproductive function.
- 29 December 2023
- Published by Wiley in Clinical Obesity
- Vol. 14 (3) , e12638
Open AccessIncreased body mass index is negatively associated with ovarian reserve as measured by anti‐Müllerian hormone in patients with polycystic ovarian syndrome
Summary: Anti‐Müllerian hormone (AMH) is commonly used as a marker of ovarian reserve. Although obesity is associated with decreased fertility, the relationship between body mass index (BMI) and AMH remains uncertain, hindering the accurate interpretation of AMH. We sought to assess the relationship between serum AMH and BMI in patients with and without polycystic ovarian syndrome (PCOS). This study analysed 500 patients at a single centre between 2020 and 2021. Patients were divided into cohorts: those with BMI 40 kg/m2. Patients with and without PCOS were included. Chi‐square tests, Fisher's exact tests, multiple linear regression analysis and independent t‐tests were performed as appropriate. In the general study population, serum AMH was not significantly different in the BMI >40 kg/m2 group compared to the BMI 2 group (4.3 ± 5.6 vs. 4.3 ± 5.6, p = .35). Patient ages between these two groups differed, with an average age of 35.4 ± 5.4 years in the BMI 2 group and 33.7 ± 5.4 years in the BMI 2 group (p = .031). Our multivariate regression analysis, which adjusted for age, demonstrated a significant interaction effect between BMI and PCOS diagnosis, indicating that the relationship between BMI and AMH is dependent on PCOS status (β = −.03, 95% confidence interval [CI]: −0.05, 0.00, p = .044). In patients without PCOS, we found a non‐significant relationship between AMH and BMI (β = .00, 95% CI −0.01, 0.01, p = .7); however, in patients with PCOS, AMH significantly decreased as BMI increased (β = −.03, 95% CI −0.06, 0.00, p = .034). BMI has an inverse association with AMH levels in patients with PCOS, indicating a need for future research to determine if that interaction represents a clinically significant negative effect on reproductive function.
- Open Access
- 22 November 2023
- Published by Elsevier in JTCVS Open
- Vol. 17, 336-343
Frailty is associated with 90-day mortality in urgent thoracic surgery conditions
- 22 November 2023
- Published by Elsevier in JTCVS Open
- Vol. 17, 336-343
Open AccessFrailty is associated with 90-day mortality in urgent thoracic surgery conditions
- 7 July 2023
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 61 (12) , 1951-1956
Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients
Objective: To compare the rates of selected nervous system, cardiovascular, and otologic abnormalities in patients with and without Treacher Collins Syndrome (TCS). Design: Retrospective TriNetX platform cohort study. Setting: Aggregated and deidentified electronic health record (EHR) data from across the United States. Patients, Participants: Patients with TCS (n = 1,114) and a propensity matched control cohort without TCS (n = 1,114 matched from n = 110,368,585). Main Outcome Measured: Prevalence and relative risk (RR) of selected diagnoses in a propensity-matched cohort. Results: The RR of congenital malformations of the circulatory system in patients with TCS was 8.5 (95% CI 4.44-16.28). Patients with TCS also had higher rates of otologic abnormalities including conductive hearing loss (RR 44, 95% CI 24-83) and nervous system disorders including movement disorders (RR 2.60, 95% CI 1.27-5.50) and recurrent seizures (RR 4.2, 95% CI 2.12-8.33). Conclusions: We found a significantly elevated risk in TCS patients within all three systems. We postulate that the nervous system effects may be the result of one of the TCS-linked genes, for which a mutation has also been associated with progressive ataxia, cerebellar atrophy, hypomyelination, and seizures. As the previously-identified causal genes influence neural crest cells that form the head and face, these cells may also populate cardiac structures, resulting in cardiovascular abnormalities. Finally, the characteristic craniofacial abnormalities identified in TCS impair hearing and are associated with increased risk of otitis media. Our findings may help researchers to hypothesize the function of the genes underlying TCS, as well as to inform the care of affected individuals.
- 7 July 2023
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 61 (12) , 1951-1956
Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients
Objective: To compare the rates of selected nervous system, cardiovascular, and otologic abnormalities in patients with and without Treacher Collins Syndrome (TCS). Design: Retrospective TriNetX platform cohort study. Setting: Aggregated and deidentified electronic health record (EHR) data from across the United States. Patients, Participants: Patients with TCS (n = 1,114) and a propensity matched control cohort without TCS (n = 1,114 matched from n = 110,368,585). Main Outcome Measured: Prevalence and relative risk (RR) of selected diagnoses in a propensity-matched cohort. Results: The RR of congenital malformations of the circulatory system in patients with TCS was 8.5 (95% CI 4.44-16.28). Patients with TCS also had higher rates of otologic abnormalities including conductive hearing loss (RR 44, 95% CI 24-83) and nervous system disorders including movement disorders (RR 2.60, 95% CI 1.27-5.50) and recurrent seizures (RR 4.2, 95% CI 2.12-8.33). Conclusions: We found a significantly elevated risk in TCS patients within all three systems. We postulate that the nervous system effects may be the result of one of the TCS-linked genes, for which a mutation has also been associated with progressive ataxia, cerebellar atrophy, hypomyelination, and seizures. As the previously-identified causal genes influence neural crest cells that form the head and face, these cells may also populate cardiac structures, resulting in cardiovascular abnormalities. Finally, the characteristic craniofacial abnormalities identified in TCS impair hearing and are associated with increased risk of otitis media. Our findings may help researchers to hypothesize the function of the genes underlying TCS, as well as to inform the care of affected individuals.
- 10 June 2023
- Published by Taylor & Francis in Medical Teacher
- Vol. 45 (12) , 1395-1403
Neglect as an undefined and overlooked aspect of medical student mistreatment: A systematic review of the literature
Although the mistreatment of medical students is a well-researched topic, the scope of mistreatment often leaves out neglect, a subtype for which there is no accepted definition based in the published literature. This review sought to summarize the existing data on the prevalence and descriptors of neglect, identify strategies seen in the literature designed to improve it, and offer a synthesized definition of this phenomenon to guide future research. Following PRISMA guidelines, a relevant systematic literature search from 2000 to April 2021 was performed to identify literature on neglect in clinical settings within American medical schools. Neglect, a poorly defined phenomenon in medical education related to the suboptimal learning environment, is often excluded from research on medical student mistreatment. Neglect is a barrier to a successful learning environment, yet a paucity of data and the heterogeneous nature of the present literature render it difficult to estimate its true prevalence. Studies that include neglect frequently assess it solely as the result of identity discrimination or stated career interests. Recent interventions include promoting longitudinal relationships between students and clinical faculty and establishing teaching expectations. Neglect is the mistreatment of medical students by the medical care team via a lack of meaningful inclusion in the clinical environment such that it has a notable negative impact on learning and student well-being, regardless of intentionality. An established definition that is grounded in the literature is required to create a common point of reference and understand its true prevalence, its associated variables, and the best mitigation strategies, as well as to guide future research, which should examine neglect independently and as a consequence of personal and professional identities.
- 10 June 2023
- Published by Taylor & Francis in Medical Teacher
- Vol. 45 (12) , 1395-1403
Neglect as an undefined and overlooked aspect of medical student mistreatment: A systematic review of the literature
Although the mistreatment of medical students is a well-researched topic, the scope of mistreatment often leaves out neglect, a subtype for which there is no accepted definition based in the published literature. This review sought to summarize the existing data on the prevalence and descriptors of neglect, identify strategies seen in the literature designed to improve it, and offer a synthesized definition of this phenomenon to guide future research. Following PRISMA guidelines, a relevant systematic literature search from 2000 to April 2021 was performed to identify literature on neglect in clinical settings within American medical schools. Neglect, a poorly defined phenomenon in medical education related to the suboptimal learning environment, is often excluded from research on medical student mistreatment. Neglect is a barrier to a successful learning environment, yet a paucity of data and the heterogeneous nature of the present literature render it difficult to estimate its true prevalence. Studies that include neglect frequently assess it solely as the result of identity discrimination or stated career interests. Recent interventions include promoting longitudinal relationships between students and clinical faculty and establishing teaching expectations. Neglect is the mistreatment of medical students by the medical care team via a lack of meaningful inclusion in the clinical environment such that it has a notable negative impact on learning and student well-being, regardless of intentionality. An established definition that is grounded in the literature is required to create a common point of reference and understand its true prevalence, its associated variables, and the best mitigation strategies, as well as to guide future research, which should examine neglect independently and as a consequence of personal and professional identities.
- Open Access
- 30 September 2022
- Published by Wiley in Clinical Obesity
- Vol. 12 (6) , e12559
The relationship between anti‐Müllerian hormone, body mass index and weight loss: A review of the literature
Summary: Anti‐Müllerian hormone (AMH) is commonly used as a proxy for ovarian reserve due to its secretion by antral follicles. It is considered a metric for prediction of ovarian response to certain assisted reproduction therapies. As obesity has a negative impact on fertility, it is important to establish whether obesity‐induced hormonal changes influence AMH levels, if and how weight loss affects AMH, and if that influence represents altered reproductive function. The aim of this study was to review the existing literature on the effects of body mass index and weight loss on AMH levels. A PubMed literature keyword search with relevant terms was performed to identify studies that have reported on the AMH/BMI relationship in cohorts with or without polycystic ovarian syndrome (PCOS). A second search was performed to gather publications on weight loss and AMH. Both searches were filtered for all full‐text, English‐language, adult‐female and human‐only literature through 1 January 2022. The relationship between AMH and body mass index (BMI) in reproductive‐aged women remains inconclusive, with studies in women with and without PCOS producing mixed results. Research in this area is currently limited by failure to analyse the full spectrum of obesity, hindering generalization to a global population increasingly affected by the condition. Some authors pointed to evidence of race/ethnicity as a confounding factor of the relationship, but results between studies are contradictory. Limited evidence on weight loss suggests it may decrease AMH levels despite improving fertility outcomes, particularly after bariatric surgery. The impact of BMI and weight loss on AMH levels has not been conclusively established. Future studies will require appropriate design and sample size calculations, consideration for additional potential confounding factors and inclusion of higher BMIs and a thorough analysis of the full range of obesity.
- 30 September 2022
- Published by Wiley in Clinical Obesity
- Vol. 12 (6) , e12559
Open AccessThe relationship between anti‐Müllerian hormone, body mass index and weight loss: A review of the literature
Summary: Anti‐Müllerian hormone (AMH) is commonly used as a proxy for ovarian reserve due to its secretion by antral follicles. It is considered a metric for prediction of ovarian response to certain assisted reproduction therapies. As obesity has a negative impact on fertility, it is important to establish whether obesity‐induced hormonal changes influence AMH levels, if and how weight loss affects AMH, and if that influence represents altered reproductive function. The aim of this study was to review the existing literature on the effects of body mass index and weight loss on AMH levels. A PubMed literature keyword search with relevant terms was performed to identify studies that have reported on the AMH/BMI relationship in cohorts with or without polycystic ovarian syndrome (PCOS). A second search was performed to gather publications on weight loss and AMH. Both searches were filtered for all full‐text, English‐language, adult‐female and human‐only literature through 1 January 2022. The relationship between AMH and body mass index (BMI) in reproductive‐aged women remains inconclusive, with studies in women with and without PCOS producing mixed results. Research in this area is currently limited by failure to analyse the full spectrum of obesity, hindering generalization to a global population increasingly affected by the condition. Some authors pointed to evidence of race/ethnicity as a confounding factor of the relationship, but results between studies are contradictory. Limited evidence on weight loss suggests it may decrease AMH levels despite improving fertility outcomes, particularly after bariatric surgery. The impact of BMI and weight loss on AMH levels has not been conclusively established. Future studies will require appropriate design and sample size calculations, consideration for additional potential confounding factors and inclusion of higher BMIs and a thorough analysis of the full range of obesity.
- 1 July 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (9) , e3963
Letter to the Editor From Kloos: “Evaluation of Female Fertility—AMH and Ovarian Reserve Testing”
Jacqueline Kloos, BA, MD; Letter to the Editor from Kloos: “Evaluation of Female Fertility – AMH and Ovarian Reserve Testing”, The Journal of Clinical Endocrino
- 1 July 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (9) , e3963
Letter to the Editor From Kloos: “Evaluation of Female Fertility—AMH and Ovarian Reserve Testing”
Jacqueline Kloos, BA, MD; Letter to the Editor from Kloos: “Evaluation of Female Fertility – AMH and Ovarian Reserve Testing”, The Journal of Clinical Endocrino
- 30 October 2014
- Published by Wiley in Journal of Genetic Counseling
- Vol. 24 (4) , 626-634
Genetic Counselors’ and Genetic Counseling Students’ Attitudes Around the Clinical Doctorate and Other Advanced Educational Options for Genetic Counselors: A Report from the Genetic Counseling Advanced Degree Task Force
Since its establishment over 40 years ago, the genetic counseling profession has grown to an estimated ~4,000 professionals in North America. While the profession has maintained the Master’s degree as the entry-level and terminal degree, many other allied health professions have added advanced training pathways, such as the clinical doctorate (ClinD) either as an optional post-professional degree or required entry-level degree. Discussions regarding advanced degrees have also occurred within the genetic counseling profession, dating back to as early as the 1980s. In 2011, the Genetic Counseling Advanced Degree Task Force (GCADTF) was convened to explore the issue again, with the goal of “[engaging] all of the professional leadership organizations in the field of genetic counseling in a decision-making process about whether the profession should move to a Clinical Doctorate”. As part of their work, the GCADTF surveyed practicing genetic counselors (n = 4,321) and genetic counseling students (n = 522) in the US and Canada regarding their interest in moving to the ClinD as the entry-level degree. This survey also included questions about other options for advanced training to generate data to inform future discussions around this very important professional issue. Herein, we describe the results of the survey, with particular attention to genetic counselor preferences for additional advanced education/certification opportunities and recommendations for future discussion.
- 30 October 2014
- Published by Wiley in Journal of Genetic Counseling
- Vol. 24 (4) , 626-634
Genetic Counselors’ and Genetic Counseling Students’ Attitudes Around the Clinical Doctorate and Other Advanced Educational Options for Genetic Counselors: A Report from the Genetic Counseling Advanced Degree Task Force
Since its establishment over 40 years ago, the genetic counseling profession has grown to an estimated ~4,000 professionals in North America. While the profession has maintained the Master’s degree as the entry-level and terminal degree, many other allied health professions have added advanced training pathways, such as the clinical doctorate (ClinD) either as an optional post-professional degree or required entry-level degree. Discussions regarding advanced degrees have also occurred within the genetic counseling profession, dating back to as early as the 1980s. In 2011, the Genetic Counseling Advanced Degree Task Force (GCADTF) was convened to explore the issue again, with the goal of “[engaging] all of the professional leadership organizations in the field of genetic counseling in a decision-making process about whether the profession should move to a Clinical Doctorate”. As part of their work, the GCADTF surveyed practicing genetic counselors (n = 4,321) and genetic counseling students (n = 522) in the US and Canada regarding their interest in moving to the ClinD as the entry-level degree. This survey also included questions about other options for advanced training to generate data to inform future discussions around this very important professional issue. Herein, we describe the results of the survey, with particular attention to genetic counselor preferences for additional advanced education/certification opportunities and recommendations for future discussion.